A phase II trial of low-dose multiagent chemotherapy with gemcitabine, docetaxel, capecitabine, and cisplatin (GTX-C) in patients with metastatic pancreatic cancer.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Dung T. Le, Daniel A. Laheru, Katrina Purtell, Jennifer N. Uram, Hao Wang, Susie Lawrence, Ellen-Lilly Foreman, Jacob Joseph David, Rose Parkinson, Dionne T Savage, Ross C. Donehower, Zeshaan Rasheed, Lei Zheng, Nilofer Saba Azad, David Cosgrove, Ana De Jesus-Acosta, Ilene Browner, Luis A. Diaz
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2589412093